Exclusive inspiring hope, delivering truth, and shaping lives through Christ-Centered Media.
A booster shot of the anti-COVID-19 vaccine developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to trial data published by the makers on Thursday. The clinical phase…